The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.
Lauren Biscaldi
Advertisement
Articles by Lauren Biscaldi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
Hantavirus Concerns and Cruise Ship Hygiene: What Infection Preventionists Need to Know
2
The Missing Link in Hand Hygiene: Why Dose Size Determines Performance
3
Aging with HIV: What the Next Major Challenge Is for Drug Development
4
Empowering Careers and Confidence in Sterile Processing: Voices From HSPA 2026
5